Russian antimonopoly body checks drug prices
This article was originally published in Scrip
Executive Summary
Russia’s federal antimonopoly service (FAS) is checking supplies of particularly expensive medicines reimbursed under a state programme for seven chronic diseases and medical conditions. The move is part of the FAS’s efforts to fight cartel agreements which, it suspects, exist in some markets including pharmaceuticals. The agency has formed a new division to tackle the cartel agreements problem.